News
-
-
PRESS RELEASE
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
Gerresheimer AG announces acquisition of Blitz LuxCo Sarl, the holding company of Bormioli Pharma Group, for around EUR 800 million. Strategic review planned for Moulded Glass business -
-
PRESS RELEASE
Gerresheimer partners with RxCap to offer connected adherence solutions
Gerresheimer partners with RxCap to offer connected adherence solutions, enabling pharmacies to provide remote therapeutic monitoring and improve health outcomes. Gerresheimer's subsidiary Centor secures distribution rights for U.S. pharmacies -
-
-
-
-
-
PRESS RELEASE
Gerresheimer Decisively Continues on Profitable Growth Course in Financial Year 2023
Gerresheimer posts strong organic revenue growth of 10.4% and adjusted EBITDA growth of 17.5% in 2023. Favorable product mix and global capacity expansion drive profitable growth. Company's high order backlog and international production capacities set the stage for continued success